316 related articles for article (PubMed ID: 16005710)
1. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias.
Cruse JM; Lewis RE; Pierce S; Lam J; Tadros Y
Exp Mol Pathol; 2005 Aug; 79(1):39-41. PubMed ID: 16005710
[TBL] [Abstract][Full Text] [Related]
2. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
3. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
4. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
5. CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia.
Arber DA; Jenkins KA; Slovak ML
Am J Pathol; 1996 Oct; 149(4):1105-10. PubMed ID: 8863659
[TBL] [Abstract][Full Text] [Related]
6. Aberrant co-expression of CD19 and CD56 as surrogate markers of acute myeloid leukemias with t(8;21) in Taiwan.
Chen SW; Li CF; Chuang SS; Tzeng CC; Hsieh YC; Lee PS; Chen CH; Huang WT; Hwang WS; Tsao CJ
Int J Lab Hematol; 2008 Apr; 30(2):133-8. PubMed ID: 18333845
[TBL] [Abstract][Full Text] [Related]
7. Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemia.
Finolezzi E; Corral L; Martelli MP; De Propris MS; Falini B; Cimino G
Haematologica; 2002 Oct; 87(10):ELT41. PubMed ID: 12368180
[No Abstract] [Full Text] [Related]
8. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias.
Lai R; Juco J; Lee SF; Nahirniak S; Etches WS
Am J Clin Pathol; 2000 Jun; 113(6):823-30. PubMed ID: 10874883
[TBL] [Abstract][Full Text] [Related]
9. Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia.
El-Sissy AH; El-Mashari MA; Bassuni WY; El-Swaayed AF
J Egypt Natl Canc Inst; 2006 Sep; 18(3):244-9. PubMed ID: 17671534
[TBL] [Abstract][Full Text] [Related]
10. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of CD7 expression in adult acute myeloid leukemia].
Saito T; Usui N; Dobashi N; Maki N; Asai O; Yano S; Kato A; Watanabe H; Katori M; Nagamine M; Ogihara A; Yamazaki H; Kobayashi T; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Jul; 39(7):481-6. PubMed ID: 9750454
[TBL] [Abstract][Full Text] [Related]
14. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia.
Vidriales MB; Orfao A; González M; Hernández JM; López-Berges MC; García MA; Cañizo MC; Caballero MD; Macedo A; Landolfi C
Leukemia; 1993 Dec; 7(12):2026-9. PubMed ID: 7504772
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of CD7 in acute myeloid leukemias with FLT3-ITD.
Juncà J; Zamora L; Cabezón M; Marcè S; Nomdedéu J
Am J Clin Pathol; 2008 Oct; 130(4):644; author reply 645. PubMed ID: 18825844
[No Abstract] [Full Text] [Related]
16. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
[TBL] [Abstract][Full Text] [Related]
17. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.
Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES
Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
19. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
20. Acute non-lymphocytic leukemia with expression of surface antigen CD7--morphological, cytochemical, immunological and ultrastructural features in eight patients.
Chopra HK; Nair CN; Barbhaya SA; Dhond SR; Badrinath Y; Kumar A; Zachariah LV; Advani SH
Indian J Cancer; 1993 Jun; 30(2):48-54. PubMed ID: 7693579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]